Back to Authors

Khouja, Mouhamad

https://orcid.org/0000-0002-9892-9461

Mayo Clinic

University Hospital Schleswig-Holstein

Citations 1

First-Mind: Final Analysis from a Phase Ib, Open-Label, Randomized Study to Assess Safety of Tafasitamab or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
Nowakowski, Grzegorz S. , Duell, Johannes , Kopečková, Kateřina , Pott, Christiane , Khouja, Mouhamad , Burke, John M. , Waldron-Lynch, Maeve, Wagner, Steve, Mukhopadhyay, Amitava , Blair, Derek, Trněný, Marek , Belada, David

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3731-3733

10.1182/blood-2022-163160 Get It